Cart
sales@molnova.com
JNJ-20788560
CAS No. 825649-28-3
JNJ-20788560( —— )
Catalog No. M34295 CAS No. 825649-28-3
JNJ-20788560 is a delta opioid receptor (DOR) agonist with analgesic activity. It is more selective for DOR than for mu opioid receptors (MOR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 334 | In Stock |
|
| 5MG | 472 | In Stock |
|
| 10MG | 644 | In Stock |
|
| 25MG | 905 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1395 | In Stock |
|
| 200MG | 1823 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-20788560
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-20788560 is a delta opioid receptor (DOR) agonist with analgesic activity. It is more selective for DOR than for mu opioid receptors (MOR).
-
DescriptionJNJ-20788560 is a selective and orally active delta opioid receptor agonist with an affinity of 2.0 nM for DOR (rat brain cortex binding assay). JNJ-20788560 also is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. JNJ-20788560 can be used for the research of the relief of inflammatory hyperalgesia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOpioid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number825649-28-3
-
Formula Weight388.5
-
Molecular FormulaC25H28N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(CC)CC)(=O)C=1C=C2C(C(C=3C(O2)=CC=CC3)=C4CC5NC(C4)CC5)=CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Codd EE, et al. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. J Pharmacol Exp Ther. 2009 Apr;329(1):241-51.?
molnova catalog
related products
-
[Nphe1]Nociceptin(1-...
Selective and competitive nociceptin receptor antagonist, devoid of any agonist activity. Binds selectively to recombinant nociceptin receptors (pKi = 8.4), and competitively antagonizes the actions of nociceptin in vitro and in vivo.
-
Naltrexone
A potent, competitive antagonist for μ, κ, δ, and σ-opioid receptors with Ki of 0.0825 nM, 0.509 nM, and 8.02 nM, for MOR, KOR, and DOR, respectively.
-
LY2795050
LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).
